Introduction: HPV detection in gynaecological samples currently provides key data in cervical pathology for diagnostic and management decisions. At present HC2 is the most clinically proven method for this purpose. Methods: Comparative study of HPV-HR detection between HC2 and Cervista™. Results: The concordance between the two methods is 96.4%. The sensitivity of Cervista™ for CIN2+ is 98.3% and specificity exceeds 98.4%. Conclusions: We conclude that Cervista™ is an appropriate method for the detection of HPV-HR in gynecological samples for screening and clinical purposes. © 2011 SEAP y SEC.
- Cervical pathology
- Human papilomavirus (HPV)